Simon Hegele strengthens the Pharma business

• Pharma business established as an independent sector
• Kai Brandes takes over the management of Simon Hegele Pharma Solutions GmbH

Since entering the pharmaceutical business at the end of 2021, the Simon Hegele Group has continuously expanded its expertise and capacities and is now taking further personnel and organizational steps to lay the foundation for the successful further development of its business with pharmaceutical customers.

Due to its importance, the pharmaceutical sector will be established as an independent sector within the Simon Hegele Group and placed under its own management. 

Kai Brandes takes over the management of the sector and the management of Simon Hegele Pharma Solutions GmbH. Mr. Brandes has extensive experience in the pharmaceutical and supply chain industry, including previous management positions at international companies such as Boehringer Ingelheim, Merck, BioNTech and Frigo-Trans.

“Over the past three years, we have stored and shipped medicines for several hundred million patients. We are certain that we can offer a certain added value here and therefore want to strategically expand this area further. We are delighted that we have been able to recruit Kai Brandes, a successful manager and expert in the pharmaceutical industry. This not only enables us to focus more strongly on the needs of our existing customers, but also creates the best conditions for acquiring new customers in the pharmaceutical sector,” says Stefan Ulrich, CEO of the Simon Hegele Group. “This will enable us to continue to offer current and future customers attractive, customized solutions along the entire supply chain. And everyone benefits from this in the end - especially the patients!”